ArticleJournal of toxicology and environmental health. Part A2025
Lipids potentially contribute to exacerbated inflammatory markers in Metabolic Syndrome mice acutely following pulmonary nanoparticle exposure.
Article in Journal of toxicology and environmental health. Part A, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Phospholipid Profiling Established by Structure-Rich Fragments for Molecular Species Level Shotgun Analysis.Rapid communications in mass spectrometry : RCM · 2026Article
- Pulmonary iron oxide (FeHuman & experimental toxicologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Metabolic Syndrome (MetS) is a combination of disturbances including dyslipidemia. Epidemiological assessments demonstrated that individuals with MetS exhibit exacerbated inflammation following particulate inhalation. The mechanisms underlying these inflammatory responses remain to be elucidated, preventing the development of strategies to protect vulnerable and prevalent populations. Lipids dysregulated in MetS are intricately involved in inflammatory regulation. Particulate exposure-induced modifications in bioactive lipids were suggested to mediate inflammation in MetS susceptible mice. To assess this hypothesis, mice were fed a control diet or a high-fat western diet for 14-weeks to generate healthy or MetS models. Mice were exposed to silver nanoparticles (AgNPs) via oropharyngeal aspiration and acute toxicity endpoints determined 4-h post-exposure. Analysis of bronchoalveolar lavage fluid demonstrated that the AgNP exposure produced neutrophilia in both healthy and MetS mouse models, which was exacerbated in MetS mice. Gene expression of chemokine ligand-1 and macrophage inflammatory protein-2 were upregulated equally in both healthy and MetS mice. Pulmonary lipids were measured utilizing an MRM profiling approach, which noted induction of pro-inflammatory lipids in MetS following AgNP exposure compared to healthy mice. Specifically, arachidonic acid, prostaglandin-E2, prostaglandin-D2, 12-hydroxyeicosatetraenoic acid, and leukotriene-B4 were elevated in MetS mice following exposure, supporting the contribution of lipids to exacerbated inflammation. Further, pulmonary gene expression demonstrated upregulation of lipid metabolism enzymes arachidonate 15-lipoxygenase and prostaglandin-endoperoxide synthase 2 in MetS mice following AgNP exposure. Overall, data suggest dysregulation of pro-inflammatory lipid mediators contributes to early exacerbations in inflammatory responses observed in MetS animals following particulate exposures that might be targeted for therapeutic interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.